{
    "clinical_study": {
        "@rank": "29950", 
        "arm_group": {
            "arm_group_label": "cohort"
        }, 
        "brief_summary": {
            "textblock": "This retrospective, observational study will assess the real world treatment outcomes in the\n      management of patients with chronic hepatitis C. No prospective assessment or procedure with\n      patients during this study will be conducted. Data will be collected from patient medical\n      records of the year 2000-2011."
        }, 
        "brief_title": "A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C", 
        "completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "condition": "Hepatitis C, Chronic", 
        "condition_browse": {
            "mesh_term": [
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis, Chronic", 
                "Hepatitis C", 
                "Hepatitis C, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients newly diagnosed with chronic hepatitis C during the year 2000 to 2010\n\n          -  Availability of data for at least 6 months following the diagnosis date\n\n        Exclusion Criteria:\n\n          -  Patients who participated in an investigational clinical trial\n\n          -  Co-infection with hepatitis A, hepatitis B, hepatitis D, and/or human\n             immunodeficiency virus (HIV)\n\n          -  Patients with known severe medical conditions that are contraindicated to HCV\n             treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Retrospective survey of medical records of patients with chronic hepatitis C"
            }
        }, 
        "enrollment": {
            "#text": "51", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 10, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01705717", 
            "org_study_id": "ML25436"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 23, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10300"
                }
            }
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_groups": "1", 
        "official_title": "Treatment Outcomes in the Management of Patients With Chronic Hepatitis C: A Case Study of Faculty of Medicine Vajira Hospital, University of Bangkok Metropolis", 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Thailand: Thailand Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Number of patients with sustained virological response after 6 months of treatment", 
            "safety_issue": "No", 
            "time_frame": "12 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01705717"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number of patients with end-of-treatment response", 
                "safety_issue": "No", 
                "time_frame": "12 years"
            }, 
            {
                "measure": "Number of patients with early virological response after 12 weeks of treatment", 
                "safety_issue": "No", 
                "time_frame": "12 years"
            }, 
            {
                "measure": "Number of patients with virological relapse", 
                "safety_issue": "No", 
                "time_frame": "12 years"
            }, 
            {
                "measure": "Number of patients with progression to cirrhosis", 
                "safety_issue": "No", 
                "time_frame": "12 years"
            }, 
            {
                "measure": "Number of patients with progression to hepatocellular carcinoma", 
                "safety_issue": "No", 
                "time_frame": "12 years"
            }, 
            {
                "measure": "Safety: incidence of adverse events", 
                "safety_issue": "No", 
                "time_frame": "12 years"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "May 2013"
    }
}